SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
How heart failure risk rises after surgery
Wed June 29th - The development of atrial fibrillation following surgery is an important risk factor for heart failure, researchers report today. More
Brain surgery benefits intracranial pressure
Wed June 29th - Craniectomy for intracranial hypertension offers significant benefit, according to new guidance, triggered by British research. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
BOOKS ON WOMEN'S HEALTH
guide to breast disorders guide to womb disorders guide to menopause Complete Women's Health: from The Royal College of Obstetricians and Gynaecologists For books and family gift ideas click here
OTHER NEWS OF INTEREST
WOMEN'S HEALTH NEWS FEED
RSS graphic XML Graphic
ENGLEMED HEALTH NEWS

Hope for new ovarian test

Tuesday March 11th, 2014

Danish researchers have developed a powerful new test for ovarian cancer.

They hope the new test could spare women the misery of having to undergo a series of tests to know if they have the cancer or not.

The researchers say their test, based on detecting a particular kind of sugar, could replace the existing blood test, which gives 94 wrong results for every six cases of cancer it detects.

The researchers at Copenhagen University have been working with a team at University College, London, on the project.

The existing test identifies the CA125 protein, which is released by a range of conditions - but the researchers say they have identified a sugar coating on the protein only present when there is cancer.

The findings have been reported in the Journal of Proteome Research - although the researchers say they will share their work with anyone who can turn it into a clinical test.

Researcher Professor Ola Blixt said: “All proteins have a type of sugar-coat – small, complicated sugar molecules that reside on a protein’s surface. When cancer is present in the body, we can observe a chemical change in this sugar-coat. It is a very complex phenomenon.

Luckily, it is very simple to investigate and determine the presence of this transformed sugar coating.”

Professor Blixt added: “We have decided to publish these results, as opposed to taking out a patent. OK, we won’t get rich, even though the market related to ovarian cancer is worth 170 million dollars annually.

"On the other hand, any manufacturer is able to include this in their existing kit. And I hope that it happens soon."

Microarray Glycoprofiling of CA125 Improves Differential Diagnosis of Ovarian Cancer J. Proteome Res. 2013, 12, 1408-1418; doi:10.1021/pr3010474

Tags: Cancer | Europe | Pharmaceuticals | UK News | Women’s Health & Gynaecology

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES